REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 138 filers reported holding REPLIMUNE GROUP INC in Q1 2023. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $11,910,880 | +887.6% | 437,900 | +527.1% | 0.04% | +700.0% |
Q3 2022 | $1,206,000 | -63.3% | 69,825 | -62.8% | 0.01% | -64.3% |
Q2 2022 | $3,283,000 | -77.4% | 187,800 | -78.0% | 0.01% | -75.9% |
Q1 2022 | $14,515,000 | +57.4% | 854,800 | +151.3% | 0.06% | +56.8% |
Q4 2021 | $9,219,000 | +48.8% | 340,200 | +110.9% | 0.04% | +32.1% |
Q2 2021 | $6,197,000 | -67.0% | 161,300 | -73.8% | 0.03% | -68.2% |
Q1 2021 | $18,772,000 | -37.3% | 615,278 | -21.6% | 0.09% | -39.7% |
Q4 2020 | $29,952,000 | +31.8% | 785,100 | -20.4% | 0.15% | +25.9% |
Q3 2020 | $22,719,000 | – | 986,916 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Omega Fund Management, LLC | 5,344,971 | $122,395,000 | 33.11% |
Corriente Advisors, LLC | 512,500 | $11,798,000 | 5.98% |
Bain Capital Life Sciences Investors, LLC | 2,122,415 | $48,858,000 | 4.55% |
BVF INC/IL | 1,691,834 | $38,946,000 | 2.12% |
Redmile Group, LLC | 3,330,999 | $76,680,000 | 1.41% |
EMERALD ADVISERS, LLC | 891,761 | $20,528,000 | 0.84% |
EMERALD MUTUAL FUND ADVISERS TRUST | 823,989 | $18,968,000 | 0.84% |
Penn Mutual Asset Management, LLC | 15,877 | $365,000 | 0.52% |
EAM Global Investors LLC | 54,274 | $1,249,000 | 0.46% |
Artal Group S.A. | 700,000 | $16,114,000 | 0.39% |